| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_213ebab4ff556c3a8d347d340ccb62bc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-20022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16322 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate |
2003-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd8d1bae049455ea9faea50832b4208f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79c23e9b6357ab37a22020424a3bad8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d144608ed18c1ee67df2150760844b44 |
| publicationDate |
2013-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2483819-C |
| titleOfInvention |
Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus |
| abstract |
The invention relates to an immunogenic or vaccine composition inducing a immune response against the native HPV Papillomaris E7 protein 16, without simultaneously inducing immunosuppression, said composition comprising, as active principle, a non-mutated E7 protein immunosuppressive protein comprising the amino acid sequence which consists of the N-terminus towards the C-terminus in: (i) the sequence amino acid 1-19 of the sequence SEQ ID N ~ 3; (ii) an acid sequence amines possessing (a) the substitution of at least one amino acid with respect to the corresponding amino acid sequence 20-29 of the sequence SEQ ID N ~ 3 or (b) the deletion of at least four consecutive amino acids, relative to the corresponding amino acid sequence 20-29 of the sequence SEQ ID N ~ 3, and (iii) the amino acid sequence 30-98 of the sequence SEQ ID N ~ 3. |
| priorityDate |
2002-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |